Literature DB >> 27064971

Cognitive Decline in Preclinical Stage 2 Alzheimer Disease and Implications for Prevention Trials.

Elizabeth C Mormino1, Kathryn V Papp2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27064971     DOI： 10.1001/jamaneurol.2016.0281

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  3 in total

1.  Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.

Authors:  Yujing Zhao; Dana L Tudorascu; Oscar L Lopez; Ann D Cohen; Chester A Mathis; Howard J Aizenstein; Julie C Price; Lewis H Kuller; M Ilyas Kamboh; Steven T DeKosky; William E Klunk; Beth E Snitz
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

Review 2.  An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia.

Authors:  Hong-Feng Zhang; Li-Bo Huang; Yan-Biao Zhong; Qi-Hui Zhou; Hui-Lin Wang; Guo-Qing Zheng; Yan Lin
Journal:  Front Aging Neurosci       Date:  2016-12-06       Impact factor: 5.750

Review 3.  Measuring cognition and function in the preclinical stage of Alzheimer's disease.

Authors:  Sandra Weintraub; Maria C Carrillo; Sarah Tomaszewski Farias; Terry E Goldberg; James A Hendrix; Judith Jaeger; David S Knopman; Jessica B Langbaum; Denise C Park; Michael T Ropacki; Sietske A M Sikkes; Kathleen A Welsh-Bohmer; Lisa J Bain; Robert Brashear; Kumar Budur; Ana Graf; Ferenc Martenyi; Marta Segardahl Storck; Christopher Randolph
Journal:  Alzheimers Dement (N Y)       Date:  2018-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.